These methods have shown 127159 and other Cyc analogues behave as potent DHFR inhibitors and may be considered for further exploration within the realm of cancer therapies, perhaps with greater emphasis on specific disease models and/or scope of utility. The gene discussed is DHFR; the disease is cancer.